Senior Management

Dr. Albert Agro

Chief Medical Officer

Dr. Albert Agro joined Cynapsus as Chief Medical Officer in August 2010. Dr. Agro also continues to serve as President and CEO of HNZ Strategic Holdings, Inc., a boutique consulting firm which provides innovative clinical development services and counselling to pharmaceutical and biotech companies developing treatments for serious disease. Prior to this role, Dr. Agro was Senior Vice President, Drug Development of TransTech Pharma (2007-2009). From 2003 to 2007, he was a Partner at Axon Medical Communications that helped build the Clinical Research arm of the business (2005-2007), as well as Vice President, Medical and Scientific Affairs at Axon (2003-2005). Dr. Agro served as Director, National Medicine, as well as Director, Immunology, Virology and Respiratory Medicine, at Boehringer Ingelheim (2000-2003). Dr. Agro also worked at Bayer Inc., as Associate Director, Cardiopulmonary Medicine (1998-2000).

Dr. Agro completed his Ph.D. from the Department of Medicine at McMaster University in 1995. After a post-doctoral fellowship at the University of Florence in Italy, Dr. Agro accepted an academic position as assistant professor, Department of Pathology and Molecular Medicine at McMaster University in Hamilton, Ontario which he still maintains today.

Traded on